** Shares of Abbott Laboratories ABT.N fall 2.85% to $126.19

** A judge in the Whitfield infant formula case granted a retrial to the plaintiffs following the October 31, 2024 verdict that handed a unanimous win in favor of Abbott and Reckitt's RKT.L unit Mead Johnson

** The ruling found the companies were not liable for failing to warn of the risks around necrotizing enterocolitis $(NEC.AU)$ in their infant formula products

** Today's ruling marks a setback following what seemed like a step in the right direction - J.P.Morgan

** ABT shares up ~8% in the last 12 months

(Reporting by Sriparna Roy in Bengaluru)

((Sriparna.Roy@thomsonreuters.com;))